Lazard Digital Health J Cap EUR

The Fund aims to achieve long-term capital appreciation. The Fund is actively managed and will pursue its objective by investing in the equities (i.e. shares) and equity related securities (i.e. shares including common and preferred stock, warrants and rights) of companies that the Investment Manager has identified as Digital Health Companies (being those that are well positioned to benefit from paradigm shifts in health care resulting from innovative scientific and technological breakthroughs that disrupt the health ecosystem). The Fund will typically invest in companies having greater than US$500m market capitalisation at the time of purchase and the Fund will usually hold between 20 and 40 such companies at any one time. The Fund's investment in equity securities may include investment in China A-Shares acquired through either the Shanghai-Hong Kong Stock Connect or the Shenzhen -Hong Kong Stock Connect. Through investment in Digital Health Companies, the Fund seeks to achieve the following social and environmental objectives: greater affordability and access to healthcare; improve customer healthcare data; and improve medical ethics and standards followed by Digital Health Companies. Digital Health Companies are rated in categories, to create an overall ESG score for each Digital Heath Company. The Fund may invest up to 20% of its assets in companies located in emerging markets. The Fund may gain exposure to the asset classes above either by investing in them directly, or by using derivatives (which are financial contracts whose value is linked to the price of an underlying investment). The currency exposures of the Fund's portfolio will be substantially hedged back into USD, being the base currency of the Fund. As a result of its use of derivatives, the Fund may be 'geared' or 'leveraged' (which can lead to a proportionately much larger movement in the value of the Fund's assets). The expected level of the Fund's leverage will be 5% of the value of the

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No